![Starter guide to induced pluripotent stem cells (iPSCs) part 1: A renaissance in regenerative medicine Starter guide to induced pluripotent stem cells (iPSCs) part 1: A renaissance in regenerative medicine](https://blog.addgene.org/hubfs/1_18_to_3_18/iPSCGuidePart1_KM_2018_2_21/Starter%20Guide%20to%20iPSCs%20Visual%20Abstract.png#keepProtocol)
Starter guide to induced pluripotent stem cells (iPSCs) part 1: A renaissance in regenerative medicine
![Induced Pluripotent Stem Cells: Therapeutic Applications in Monogenic and Metabolic Diseases, and Regulatory and Bioethical Considerations | IntechOpen Induced Pluripotent Stem Cells: Therapeutic Applications in Monogenic and Metabolic Diseases, and Regulatory and Bioethical Considerations | IntechOpen](https://cdnintech.com/media/chapter/44717/1512345123/media/image1.jpeg)
Induced Pluripotent Stem Cells: Therapeutic Applications in Monogenic and Metabolic Diseases, and Regulatory and Bioethical Considerations | IntechOpen
Induced pluripotent, embryonic stem cell research| PSC research, maintenance & workflow| Miltenyi | Miltenyi Biotec | France
![What are iPS cells? | For the Public | CiRA | Center for iPS Cell Research and Application, Kyoto University What are iPS cells? | For the Public | CiRA | Center for iPS Cell Research and Application, Kyoto University](https://www.cira.kyoto-u.ac.jp/e/faq/img/block5/doc04.jpg)
What are iPS cells? | For the Public | CiRA | Center for iPS Cell Research and Application, Kyoto University
![Starter Guide to induced Pluripotent Stem Cells (iPSCs) Part 2: Reprogramming and Transdifferentiation Starter Guide to induced Pluripotent Stem Cells (iPSCs) Part 2: Reprogramming and Transdifferentiation](https://blog.addgene.org/hubfs/4_18_to_6_18/reprogrammingTransdifferentiation_KM_2018_4_13/Reprogramming%20and%20Transdifferentiation%20Infographic.png)
Starter Guide to induced Pluripotent Stem Cells (iPSCs) Part 2: Reprogramming and Transdifferentiation
![JCM | Free Full-Text | The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges JCM | Free Full-Text | The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges](https://www.mdpi.com/jcm/jcm-04-00037/article_deploy/html/images/jcm-04-00037-g001.png)